Capital Analysts, LLC Astrazeneca PLC Transaction History

Capital Analysts, LLC

$3.43 Billion
Q3 2025

A detailed history of Capital Analysts, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital Analysts, LLC holds 877 shares of AZN stock, worth $78,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares

877

Previous 883 0.68%

Holding current value

$78,403

Previous $62,000 8.06%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$68.72 - $82.11 $412 - $492	-6 Reduced 0.68%	877 $67,000
Q2 2025 Aug 13, 2025	SELL	$64.87 - $75.0 $11,352 - $13,125	-175 Reduced 16.54%	883 $62,000
Q1 2025 May 14, 2025	BUY	$65.37 - $77.96 $6,994 - $8,341	107 Added 11.25%	1,058 $78,000
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $1,327 - $1,671	21 Added 2.26%	951 $62,000
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $34,578 - $39,516	451 Added 94.15%	930 $73,000

Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $1,269 - $1,535	19 Added 4.13%	479 $38,000
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $5,126 - $5,843	84 Added 22.34%	460 $31,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $194 - $215	3 Added 0.8%	376 $25,000
Q1 2023 May 05, 2023	BUY	$63.15 - $71.6 $315 - $358	5 Added 1.36%	373 $26,000
Q4 2022 Feb 08, 2023	SELL	$54.21 - $70.44 $5,475 - $7,114	-101 Reduced 21.54%	368 $25,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $11,028 - $28,236	208 Added 79.69%	469 $26,000
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $222 - $268	4 Added 1.56%	261 $17,000
Q3 2021 Nov 04, 2021	SELL	$55.56 - $60.79 $2,333 - $2,553	-42 Reduced 14.05%	257 $15,000
Q2 2021 Nov 15, 2021	SELL	$48.42 - $60.18 $26,631 - $33,099	-550 Reduced 64.78%	299 $18,000
Q2 2021 Aug 05, 2021	BUY	$48.42 - $60.18 $26,631 - $33,099	550 Added 183.95%	849 $51,000
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $12,025 - $13,882	255 Added 579.55%	299 $15,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $2,134 - $2,552	44 New	44 $2,000
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $638 - $774	-18 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $565,534 - $628,314	-17,153 Reduced 99.9%	18 $1,000
Q4 2017 Feb 12, 2018	BUY	$32.09 - $34.78 $551,017 - $597,207	17,171	17,171 $1.23 Million

Others Institutions Holding AZN

# of Institutions

1,498

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Account

Capital Analysts, LLC Astrazeneca PLC Transaction History